Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Bezlotoxumab Versus FMT for Multiple Recurrent CDI [Phase 4]
Phase 4 trial comparing bezlotoxumab to FMT for multiple recurrent Clostridioides difficile infection was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection [Phase 3]
Phase 3 trial comparing ridinilazole to vancomycin for Clostridioides difficile infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants [Phase 2]
A Phase 2 clinical trial evaluating the safety and immunogenicity of the Boostrix vaccine in pregnant Malian women and their infants, with r…
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age [Phase 3]
Phase 3 trial update evaluating lot consistency of a Clostridium difficile vaccine in healthy adults 65-85 years old; results posted after c…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff [Phase 2]
Phase 2 trial evaluating oral Full-Spectrum Microbiota (CP101) for efficacy, safety, and tolerability in recurrent Clostridioides difficile …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation [Phase 2]
Phase 2 trial investigating gut recolonization by fecal transplantation for recurrent Clostridioides difficile infection completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI) [Phase 2]
Phase 2 dose-ranging study evaluating an orally administered lyophilized fecal microbiota product for recurrent Clostridium difficile infect…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection [Phase 2]
Phase 2 trial update comparing lyophilized fecal transplant to lyophilized fecal filtrate for recurrent Clostridioides difficile infection h…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff [Phase 2, Phase 3]
A comparative trial evaluating capsule-delivered fecal microbiota transplantation versus colonoscopy-delivered FMT for recurrent Clostridioi…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Impact of Oral Antibiotic Treatment on C. Difficile [Phase 4]
Phase 4 clinical trial assessing the impact of oral antibiotic treatment on C. difficile outcomes; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea [Phase 1, Phase 2]
The document reports Phase 1 and Phase 2 results for fecal microbiota transplantation to treat recurrent Clostridioides difficile infection.
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) [Phase 2, Phase 3]
Actelion-sponsored pediatric trial comparing cadazolid to vancomycin for Clostridioides difficile infection has terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route [Phase 1, Phase 2]
A combined Phase 1/Phase 2 clinical trial evaluating fecal microbiota transplantation via retention enema or oral route for recurrent Clostr…
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) [Phase 3]
This completed Phase 3 study evaluated fidaxomicin (oral suspension or tablets) versus vancomycin (oral liquid or capsules) for pediatric Cl…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection [Phase 2]
Phase 2 trial results for a microbiota restoration therapy in recurrent Clostridium difficile infection have been completed and results post…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) [Phase 2]
Phase 2 trial SER-109 vs placebo for preventing recurrent Clostridioides difficile infection has completed, with results posted in 2018. The…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults [Phase 2]
The document reports the completion of a Phase 2 trial evaluating multiple formulations of a Clostridioides difficile toxoid vaccine given o…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan [Phase 1, Phase 2]
Completion of Phase 1/Phase 2 evaluation of a candidate Clostridioides difficile toxoid vaccine in healthy adults aged 40-75 years in Japan.
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults [Phase 1]
Phase 1 trial evaluating safety, tolerability, and immunogenicity of a Clostridioides difficile vaccine in Japanese adults has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea [Phase 3]
Phase 3 trial comparing cadazolid to vancomycin for Clostridioides difficile infection has completed and posted results, including safety da…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of cadazolid versus vancomycin for Clostridioides difficile infection has completed and r…
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics [Phase 4]
Phase 4 trial evaluating oral vancomycin for primary prophylaxis of Clostridioides difficile infection in patients on high-risk antibiotics;…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) [Phase 2]
Phase 2 trial comparing Ridinilazole to Fidaxomicin for treating Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
A completed clinical trial describes the use and management of fidaxomicin in hospitalized patients with Clostridioides difficile infection.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
A multi-site clinical evaluation of the ARIES Clostridioides difficile assay in symptomatic patients has completed, with results reported fr…